A study by Human Brain Project (HBP) researchers has identified a new marker for predicting the clinical outcome of patients with Amyotrophic Lateral Sclerosis (ALS) through magnetoencephalography. This marker can be measured ...
Sep 30, 2022
0
142
A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Sep 30, 2022
0
8
Frontotemporal dementia (FTD), a common form of early-onset dementia, is marked by impairments in behavior, language, and sometimes motor function. Unlike Alzheimer's Disease (AD), researchers and clinicians have been unable ...
Sep 23, 2022
0
84
In the 150 years since ALS, or amyotrophic lateral sclerosis, first came to scientific light, there remains no cure for the progressive, fatal neurodegenerative condition. But more research continues to uncover environmental ...
Sep 16, 2022
0
30
Infections treated with specialty hospital care in early- and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), but not amyotrophic lateral sclerosis (ALS), according ...
Sep 15, 2022
0
218
A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the ...
Sep 8, 2022
0
26
A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.
Sep 7, 2022
0
4
Massive, repetitive stretches of DNA in the human genome may harbor hints about the onset of a rare, inherited neurodegenerative disorder called ataxia-telangiectasia as well as other related diseases, a new Yale School of ...
Sep 6, 2022
0
85
Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially ...
Sep 5, 2022
0
157
Amyotrophic lateral sclerosis (ALS) is an intractable disease of motor neurons for which there is no radical cure in current medicine. Without a ventilator, most people die within 3–5 years of onset due to weakness of the ...
Aug 22, 2022
0
6
